956 related articles for article (PubMed ID: 34009000)
1. Frequency and Characteristics of Nodal and Deltoid FDG and
Schroeder DG; Jang S; Johnson DR; Takahashi H; Navin PJ; Broski SM; Thorpe MP; Johnson GB; Young JR
AJR Am J Roentgenol; 2021 Nov; 217(5):1206-1216. PubMed ID: 34009000
[No Abstract] [Full Text] [Related]
2. [
Skawran S; Gennari AG; Dittli M; Treyer V; Muehlematter UJ; Maurer A; Burger IA; Mader C; Messerli O; Grünig H; Gebhard C; Huellner MW; Curioni-Fontecedro A; Berger C; Messerli M
Eur Radiol; 2022 Jan; 32(1):508-516. PubMed ID: 34156552
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 Vaccination-Related Uptake on FDG PET/CT: An Emerging Dilemma and Suggestions for Management.
McIntosh LJ; Bankier AA; Vijayaraghavan GR; Licho R; Rosen MP
AJR Am J Roentgenol; 2021 Oct; 217(4):975-983. PubMed ID: 33646823
[TBL] [Abstract][Full Text] [Related]
4. The systemic impact of different COVID-19 vaccines in 2-[18F] FDG-PET/CT.
Nazerani-Zemann T; Pernthaler B; Schwantzer G; Gstettner C
Sci Rep; 2023 Dec; 13(1):21838. PubMed ID: 38071353
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 vaccine related hypermetabolic lymph nodes on PET/CT: Implications of inflammatory findings in cancer imaging.
Calabria F; Bagnato A; Guadagnino G; Toteda M; Lanzillotta A; Cardei S; Tavolaro R; Leporace M
Oncol Res; 2023; 31(2):117-124. PubMed ID: 37304242
[TBL] [Abstract][Full Text] [Related]
6. Vaccine-Related Lymph Nodes: The Emerging Pitfalls of 18F-Fluorocholine and 68Ga-PSMA-11 PET/CT in the Era of COVID-19 Vaccination.
Ah-Thiane L; Ferrer L; Maucherat B; Fleury V; Le Thiec M; Rusu D; Rousseau C
Clin Nucl Med; 2022 Jul; 47(7):575-582. PubMed ID: 35675134
[TBL] [Abstract][Full Text] [Related]
7. [
Kubota K; Saginoya T; Ishiwata K; Nakasato T; Munechika H
Ann Nucl Med; 2022 Apr; 36(4):340-350. PubMed ID: 35098436
[TBL] [Abstract][Full Text] [Related]
8. Axillary lymph node characteristics in breast cancer patients versus post-COVID-19 vaccination: Overview of current evidence per imaging modality.
van Nijnatten TJA; Jochelson MS; Lobbes MBI
Eur J Radiol; 2022 Jul; 152():110334. PubMed ID: 35512513
[TBL] [Abstract][Full Text] [Related]
9. Examination of iatrogenic FDG accumulation after COVID-19 vaccination.
Takahashi K; Manabe O; Shizukuishi K; Shibata H; Kawakami H; Otsuka A; Oyama-Manabe N
Ann Nucl Med; 2024 Jun; 38(6):409-417. PubMed ID: 38563890
[TBL] [Abstract][Full Text] [Related]
10. The Effects of CoronaVac (Sinovac) and BNT162b2 (BioNTech/Pfizer) Vaccination on Oncologic
Şan H; Alagöz E
Mol Imaging Radionucl Ther; 2022 Oct; 31(3):179-190. PubMed ID: 36268854
[TBL] [Abstract][Full Text] [Related]
11. FDG PET/CT radiomics as a tool to differentiate between reactive axillary lymphadenopathy following COVID-19 vaccination and metastatic breast cancer axillary lymphadenopathy: a pilot study.
Eifer M; Pinian H; Klang E; Alhoubani Y; Kanana N; Tau N; Davidson T; Konen E; Catalano OA; Eshet Y; Domachevsky L
Eur Radiol; 2022 Sep; 32(9):5921-5929. PubMed ID: 35385985
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of metabolic changes in FDG PET/CT imaging after mRNA-based COVID-19 vaccination.
İşgören S; Köroğlu G; Görür GD; Demir H
Turk J Med Sci; 2022 Dec; 52(6):1745-1753. PubMed ID: 36945983
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 mRNA Vaccination: Age and Immune Status and Its Association with Axillary Lymph Node PET/CT Uptake.
Eifer M; Tau N; Alhoubani Y; Kanana N; Domachevsky L; Shams J; Keret N; Gorfine M; Eshet Y
J Nucl Med; 2022 Jan; 63(1):134-139. PubMed ID: 33893188
[TBL] [Abstract][Full Text] [Related]
14. Hypermetabolic lymphadenopathy following administration of BNT162b2 mRNA Covid-19 vaccine: incidence assessed by [
Cohen D; Krauthammer SH; Wolf I; Even-Sapir E
Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1854-1863. PubMed ID: 33774684
[TBL] [Abstract][Full Text] [Related]
15. Fine needle aspiration in COVID-19 vaccine-associated lymphadenopathy.
Hagen C; Nowack M; Messerli M; Saro F; Mangold F; Bode PK
Swiss Med Wkly; 2021 Jul; 151():w20557. PubMed ID: 34286849
[TBL] [Abstract][Full Text] [Related]
16. Reactive Axillary Lymphadenopathy to COVID-19 Vaccination on
Smith MV; Yang M
J Nucl Med Technol; 2021 Sep; 49(3):286-287. PubMed ID: 33820864
[TBL] [Abstract][Full Text] [Related]
17. Lymphadenopathy post-COVID-19 vaccination with increased FDG uptake may be falsely attributed to oncological disorders: A systematic review.
Bshesh K; Khan W; Vattoth AL; Janjua E; Nauman A; Almasri M; Mohamed Ali A; Ramadorai V; Mushannen B; AlSubaie M; Mohammed I; Hammoud M; Paul P; Alkaabi H; Haji A; Laws S; Zakaria D
J Med Virol; 2022 May; 94(5):1833-1845. PubMed ID: 35060149
[TBL] [Abstract][Full Text] [Related]
18. A sigh of relief: vaccine-associated hypermetabolic lymphadenopathy following the third COVID-19 vaccine dose is short in duration and uncommonly interferes with the interpretation of [
Cohen D; Hazut Krauthammer S; Wolf I; Even-Sapir E
Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1338-1344. PubMed ID: 34651230
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 Vaccine-Associated Subclinical Axillary Lymphadenopathy on Screening Mammogram.
Raj S; Ogola G; Han J
Acad Radiol; 2022 Apr; 29(4):501-507. PubMed ID: 34906409
[TBL] [Abstract][Full Text] [Related]
20. Axillary Lymphadenopathy after Pfizer-BioNTech and Moderna COVID-19 Vaccination: MRI Evaluation.
Yoshikawa T; Miki S; Nakao T; Koshino S; Hayashi N; Abe O
Radiology; 2023 Jan; 306(1):270-278. PubMed ID: 36098641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
